Rumah > Produk > Bahan Farmaseutikal Aktif (API) > Lifitegrast > N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-L-phenylalanine
N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-L-phenylalanine

N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-L-phenylalanine

Nama produk Cina: Litalast
Alias ​​Cina: (S)-2-[2-(benzofuran-6-karbonil)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido]- 3-(3-methanesulfonylphenyl)asid propionik ;N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-L-phenylalanine
Nama produk Inggeris: Lifitegrast
Cas# 1025967-78-5
Formula molekul: C29H24Cl2N2O7S
Berat molekul: 615.4810
Rupa dan sifat: pepejal putih hingga putih pudar

Hantar Pertanyaan

Penerangan Produk

Formula

Nama produk Cina: Litalast

Alias ​​Cina: (S)-2-[2-(benzofuran-6-karbonil)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido]- 3-(3-methanesulfonylphenyl)asid propionik ; N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-L-phenylalanine

Nama produk Inggeris: Lifitegrast

Cas# 1025967-78-5

Formula molekul: C29H24Cl2N2O7S

Berat molekul: 615.4810

Rupa dan sifat: pepejal putih hingga putih pudar

N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-L-phenylalanine adalah untuk ubat mata kering, ubat titis mata.


Teg Panas: N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-L-phenylalanine, China, Pengilang, Pembekal , Kilang, Kualiti Tinggi

Kategori Berkaitan

Hantar Pertanyaan

Sila berasa bebas untuk memberikan pertanyaan anda dalam borang di bawah. Kami akan membalas anda dalam masa 24 jam.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept